Healthcare provider profile · identity verified

Clare A Cullen, APNP

Nurse Practitioner · PLOVER, WI · NPI 1831246172

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	637	174
Amlodipine Besylate	Amlodipine Besylate	472	123
Lisinopril	Lisinopril	442	131
Levothyroxine Sodium	Levothyroxine Sodium	379	86
Metoprolol Succinate	Metoprolol Succinate	290	83
Rosuvastatin Calcium	Rosuvastatin Calcium	285	89
Omeprazole	Omeprazole	270	79
Losartan Potassium	Losartan Potassium	231	67
Gabapentin	Gabapentin	206	54
Furosemide	Furosemide	181	50
Metformin Hcl Er	Metformin Hcl	175	53
Hydrochlorothiazide	Hydrochlorothiazide	169	48
Simvastatin	Simvastatin	144	35
Potassium Chloride	Potassium Chloride	120	24
Sertraline Hcl	Sertraline Hcl	120	28
Tamsulosin Hcl	Tamsulosin Hcl	110	30
Pravastatin Sodium	Pravastatin Sodium	108	29
Albuterol Sulfate Hfa	Albuterol Sulfate	104	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	25
Trazodone Hcl	Trazodone Hcl	98	28
Eliquis	Apixaban	95	25
Metformin Hcl	Metformin Hcl	95	27
Fluticasone Propionate	Fluticasone Propionate	92	36
Alendronate Sodium	Alendronate Sodium	85	27
Warfarin Sodium	Warfarin Sodium	84	18
Metoprolol Tartrate	Metoprolol Tartrate	82	23
Tramadol Hcl	Tramadol Hcl	79	23
Allopurinol	Allopurinol	78	19
Pantoprazole Sodium	Pantoprazole Sodium	78	22
Donepezil Hcl	Donepezil Hcl	77	12
Finasteride	Finasteride	74	19
Escitalopram Oxalate	Escitalopram Oxalate	72	26
Amoxicillin	Amoxicillin	65	40
Zolpidem Tartrate	Zolpidem Tartrate	63	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	14
Citalopram Hbr	Citalopram Hydrobromide	57	16
Valsartan	Valsartan	57	14
Duloxetine Hcl	Duloxetine Hcl	54	17
Bupropion Xl	Bupropion Hcl	52	15
Fenofibrate	Fenofibrate	49	15
Fluoxetine Hcl	Fluoxetine Hcl	47	11
Famotidine	Famotidine	46	18
Mirtazapine	Mirtazapine	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	13
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	43	18
Hydroxyzine Hcl	Hydroxyzine Hcl	43	16
Pioglitazone Hcl	Pioglitazone Hcl	43	12
Carvedilol	Carvedilol	39	11
Ezetimibe	Ezetimibe	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	15
Meloxicam	Meloxicam	33	11
Glipizide	Glipizide	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	17
Celecoxib	Celecoxib	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Prednisone	Prednisone	27	16
Lovastatin	Lovastatin	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Baclofen	Baclofen	22	suppressed
Estradiol	Estradiol	22	12
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Alprazolam	Alprazolam	21	14
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Ozempic	Semaglutide	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Cefdinir	Cefdinir	19	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nystatin	Nystatin	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Atenolol	Atenolol	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Colchicine	Colchicine	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Nystop	Nystatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Linzess	Linaclotide	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Torsemide	Torsemide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Methimazole	Methimazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error